Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives Article

Arrieta, Alejandro, Page, Timothy F, Veledar, Emir et al. (2017). Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives . 12(1), 10.1371/journal.pone.0169761

Open Access

keywords

  • COST-EFFECTIVENESS
  • DISEASE
  • ERA
  • HYPERCHOLESTEROLEMIA
  • INSURANCE
  • Multidisciplinary Sciences
  • PREVENTION
  • Science & Technology
  • Science & Technology - Other Topics
  • THERAPY

Digital Object Identifier (DOI)

volume

  • 12

issue

  • 1